A Different Overview of Staging PET/CT Images in Patients with Esophageal Cancer: the Role of Textural Analysis with Machine Learning Methods
Overview
Affiliations
Objective: This study evaluates the ability of several machine learning (ML) algorithms, developed using volumetric and texture data extracted from baseline F-FDG PET/CT studies performed initial staging of patient with esophageal cancer (EC), to predict survival and histopathology.
Methods: The initial staging F-FDG PET/CT images obtained on newly diagnosed EC patients between January 2008 and June 2019 were evaluated using LIFEx software. A region of interest (ROI) of the primary tumor was created and volumetric and textural features were obtained. A significant relationship between these features and pathological subtypes, 1-year, and 5-year survival was investigated. Due to the nonhomogeneity of the data, nonparametric test (The Mann-Whitney U test) was used for each feature, in pairwise comparisons of independent variables. A p value of < 0.05 was considered significant. Receiver operating curve (ROC) analysis was performed for features with p < 0.05. Correlation between the significant features was evaluated with Spearman correlation test; features with correlation coefficient < 0.8 were evaluated with several ML algorithms.
Results: In predicting survival in a 1-year follow-up J48 was obtained as the most successful algorithm (AUC: 0.581, PRC: 0.565, MCC: 0.258, acc: 64.29%). 5-year survival results were more promising than 1-year survival results with (AUC: 0.820, PRC: 0.860, MCC: 271, acc: 81.36%) by logistic regression. It is revealed that the most successful algorithm was naive bayes (AUC: 0.680 PRC: 0.776, MCC: 0.298, acc: 82.66%) in the histopathological discrimination.
Conclusion: Texture analysis with ML algorithms could be predictive of overall survival and discriminating histopathological subtypes of EC.
Artificial intelligence: clinical applications and future advancement in gastrointestinal cancers.
Akbari A, Adabi M, Masoodi M, Namazi A, Mansouri F, Tabaeian S Front Artif Intell. 2025; 7:1446693.
PMID: 39764458 PMC: 11701808. DOI: 10.3389/frai.2024.1446693.
Yuan P, Huang Z, Yang Y, Bao F, Sun K, Chao F Cancer Imaging. 2024; 24(1):153.
PMID: 39533388 PMC: 11556142. DOI: 10.1186/s40644-024-00799-0.
The Applications of Artificial Intelligence in Digestive System Neoplasms: A Review.
Zhang S, Mu W, Dong D, Wei J, Fang M, Shao L Health Data Sci. 2024; 3:0005.
PMID: 38487199 PMC: 10877701. DOI: 10.34133/hds.0005.
Philip M, Welch A, McKiddie F, Nath M Cancer Med. 2023; 12(15):16181-16194.
PMID: 37353996 PMC: 10469753. DOI: 10.1002/cam4.6278.
Menon N, Guidozzi N, Chidambaram S, Markar S Dis Esophagus. 2023; 36(6).
PMID: 37236811 PMC: 10789236. DOI: 10.1093/dote/doad034.